Avosb / iStockphoto.com
8 January 2018Americas
PTAB dismisses Native American tribe information request
The Patent Trial and Appeal Board (PTAB) has denied an information request by a Native American tribe, deeming it improper for a number of reasons.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
4 January 2018 A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board judges overseeing inter partes reviews involving the tribe.
Big Pharma
10 January 2018 Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).
Americas
26 February 2018 The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.
Editor's picks
Editor's picks
Americas
4 January 2018 A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board judges overseeing inter partes reviews involving the tribe.
Big Pharma
10 January 2018 Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).
Americas
26 February 2018 The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.
Americas
4 January 2018 A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board judges overseeing inter partes reviews involving the tribe.
Big Pharma
10 January 2018 Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).
Americas
26 February 2018 The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.